ProCE Banner Activity

Novel Treatment Strategies for Myeloproliferative Neoplasms: What’s New From ASCO and EHA 2019

Clinical Thought
In this commentary, I review key data from ASCO and EHA 2019 on investigational treatments for patients with myelofibrosis or polycythemia vera.

Released: July 08, 2019

Expiration: July 06, 2020

No longer available for credit.

Share

Faculty

Brady L. Stein

Brady L. Stein, MD, MHS

Professor of Medicine
Department of Hematology/Oncology
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Celgene

Incyte Corporation

Faculty Disclosure

Primary Author

Brady L. Stein, MD, MHS

Professor of Medicine
Department of Hematology/Oncology
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Brady L. Stein, MD, MHS, has disclosed that he has received consulting fees from Apexx Oncology and Celgene.